China Medical System Holdings Limited (HKG:0867)
Hong Kong · Delayed Price · Currency is HKD 12.96
-0.06 (-0.46%)
Mar 17, 2026, 4:08 PM HKT
HKG:0867 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,212 | 7,469 | 8,013 | 9,150 | 8,337 | |
Revenue Growth (YoY) | 9.95% | -6.79% | -12.43% | 9.75% | 20.03% |
Cost of Revenue | 2,341 | 2,047 | 1,937 | 2,115 | 2,090 |
Gross Profit | 5,872 | 5,422 | 6,076 | 7,036 | 6,247 |
Selling, General & Admin | 3,708 | 3,442 | 3,168 | 3,358 | 2,981 |
Research & Development | 585.02 | 329.98 | 195.13 | 125.43 | 114.76 |
Operating Expenses | 4,293 | 3,772 | 3,363 | 3,483 | 3,096 |
Operating Income | 1,578 | 1,650 | 2,713 | 3,552 | 3,151 |
Interest Expense | -20.3 | -38.61 | -46.25 | -49.09 | -28.27 |
Interest & Investment Income | - | 128.06 | 177.1 | 105.52 | 81.85 |
Earnings From Equity Investments | 242.3 | 341.3 | 277.87 | 65.06 | 75.35 |
Currency Exchange Gain (Loss) | - | -53.15 | 31.54 | -126.21 | 22.62 |
Other Non Operating Income (Expenses) | 302.58 | 91.91 | -46.82 | 127.48 | 58.57 |
EBT Excluding Unusual Items | 2,103 | 2,120 | 3,106 | 3,675 | 3,361 |
Impairment of Goodwill | - | - | - | -60 | -20 |
Gain (Loss) on Sale of Investments | - | -109.03 | -60.75 | 150.01 | 115.66 |
Gain (Loss) on Sale of Assets | - | 0.5 | -0.27 | -0.4 | -0.23 |
Asset Writedown | - | -1.15 | -171.49 | -2 | - |
Pretax Income | 2,103 | 2,010 | 2,874 | 3,763 | 3,457 |
Income Tax Expense | 659.78 | 397.23 | 489.34 | 486.66 | 431.33 |
Earnings From Continuing Operations | 1,443 | 1,613 | 2,384 | 3,276 | 3,025 |
Minority Interest in Earnings | 45.62 | 6.71 | 16.51 | -17.2 | -7.86 |
Net Income | 1,489 | 1,620 | 2,401 | 3,259 | 3,017 |
Net Income to Common | 1,489 | 1,620 | 2,401 | 3,259 | 3,017 |
Net Income Growth | -8.08% | -32.53% | -26.33% | 8.01% | 19.25% |
Shares Outstanding (Basic) | 2,419 | 2,427 | 2,452 | 2,454 | 2,468 |
Shares Outstanding (Diluted) | 2,419 | 2,427 | 2,452 | 2,454 | 2,468 |
Shares Change (YoY) | -0.33% | -1.00% | -0.08% | -0.56% | -0.17% |
EPS (Basic) | 0.62 | 0.67 | 0.98 | 1.33 | 1.22 |
EPS (Diluted) | 0.62 | 0.67 | 0.98 | 1.33 | 1.22 |
EPS Growth | -7.78% | -31.85% | -26.27% | 8.61% | 19.45% |
Free Cash Flow | 758.42 | 1,236 | 2,475 | 3,535 | 2,471 |
Free Cash Flow Per Share | 0.31 | 0.51 | 1.01 | 1.44 | 1.00 |
Dividend Per Share | - | 0.268 | 0.392 | 0.534 | 0.491 |
Dividend Growth | - | -31.55% | -26.70% | 8.84% | 18.66% |
Gross Margin | 71.50% | 72.60% | 75.82% | 76.89% | 74.93% |
Operating Margin | 19.22% | 22.10% | 33.85% | 38.82% | 37.80% |
Profit Margin | 18.13% | 21.69% | 29.96% | 35.62% | 36.19% |
Free Cash Flow Margin | 9.23% | 16.55% | 30.89% | 38.63% | 29.63% |
EBITDA | 1,814 | 1,886 | 2,922 | 3,762 | 3,357 |
EBITDA Margin | 22.09% | 25.25% | 36.47% | 41.11% | 40.27% |
D&A For EBITDA | 235.74 | 235.74 | 209.3 | 209.08 | 206.05 |
EBIT | 1,578 | 1,650 | 2,713 | 3,552 | 3,151 |
EBIT Margin | 19.22% | 22.10% | 33.85% | 38.82% | 37.80% |
Effective Tax Rate | 31.37% | 19.76% | 17.03% | 12.93% | 12.48% |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.